Scarica l'app Stockscreener
28.93
7.03%
1.90
Dopo l'orario di chiusura:
30.16
1.23
+4.25%
Precedente Chiudi:
$27.03
Aprire:
$27.26
Volume 24 ore:
161.84K
Relative Volume:
0.94
Capitalizzazione di mercato:
$478.44M
Reddito:
$3.25M
Utile/perdita netta:
$-116.80M
Rapporto P/E:
-9.4852
EPS:
-3.05
Flusso di cassa netto:
$-98.17M
1 W Prestazione:
-3.61%
1M Prestazione:
+64.10%
6M Prestazione:
+351.41%
1 anno Prestazione:
+106.64%
Intervallo 1D:
$27.07
$29.00
Intervallo di 1 settimana:
$24.25
$29.95
Portata 52W:
$5.6652
$32.35
Rapt Therapeutics Inc Stock (RAPT) Company Profile
Nome
Rapt Therapeutics Inc
Settore
Industria
Telefono
(650) 489-9000
Indirizzo
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Confronta RAPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RAPT
Rapt Therapeutics Inc
|
28.93 | 413.44M | 3.25M | -116.80M | -98.17M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-26 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-07-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2025-05-22 | Ripresa | H.C. Wainwright | Buy |
| 2024-12-26 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-11-13 | Downgrade | Stifel | Buy → Hold |
| 2024-11-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-11-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-14 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-05-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-05-10 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-02-22 | Downgrade | UBS | Buy → Neutral |
| 2024-02-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-02-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-21 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-02-16 | Iniziato | Evercore ISI | Outperform |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-09-14 | Iniziato | Berenberg | Buy |
| 2023-08-09 | Iniziato | Stifel | Buy |
| 2023-06-15 | Iniziato | Barclays | Overweight |
| 2023-01-04 | Iniziato | Guggenheim | Buy |
| 2022-12-01 | Iniziato | Goldman | Buy |
| 2022-09-21 | Iniziato | CapitalOne | Overweight |
| 2022-05-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-12-09 | Iniziato | JP Morgan | Overweight |
| 2021-08-12 | Iniziato | SVB Leerink | Outperform |
| 2021-06-21 | Iniziato | Piper Sandler | Overweight |
| 2020-06-01 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-04-13 | Iniziato | ROTH Capital | Buy |
| 2019-11-25 | Iniziato | BMO Capital Markets | Outperform |
| 2019-11-25 | Iniziato | UBS | Buy |
| 2019-11-25 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Rapt Therapeutics Inc Borsa (RAPT) Ultime notizie
FY2026 Earnings Forecast for RAPT Issued By Lifesci Capital - Defense World
How analysts rate RAPT Therapeutics Inc. stock todayMarket Trend Summary & Daily Technical Forecast Reports - newser.com
What MACD and RSI say about RAPT Therapeutics Inc.July 2025 Update & Accurate Intraday Trading Signals - newser.com
Risk adjusted return profile for RAPT Therapeutics Inc. analyzedCPI Data & Stepwise Swing Trade Plans - newser.com
What hedge fund moves indicate for RAPT Therapeutics Inc. (0RA) stockWeekly Profit Recap & Reliable Volume Spike Alerts - newser.com
What indicators show strength in RAPT Therapeutics Inc.Bear Alert & Risk Adjusted Buy/Sell Alerts - newser.com
Why retail investors favor RAPT Therapeutics Inc. stockJuly 2025 Fed Impact & Low Drawdown Investment Ideas - newser.com
Barclays Begins Coverage on Rapt Therapeutics (NASDAQ:RAPT) - Defense World
Will RAPT Therapeutics Inc. bounce back from current supportMarket Movers & Safe Entry Trade Reports - newser.com
Will RAPT Therapeutics Inc. stock maintain growth story2025 Market Outlook & Stepwise Entry and Exit Trade Signals - newser.com
Key metrics from RAPT Therapeutics Inc.’s quarterly dataPortfolio Performance Report & Verified Chart Pattern Signals - newser.com
Barclays Initiates Coverage of RAPT Therapeutics (RAPT) with Overweight Recommendation - Nasdaq
Is RAPT Therapeutics Inc. stock a buy for dividend growthJuly 2025 Volume & Stepwise Swing Trade Plans - newser.com
Will RAPT Therapeutics Inc. price bounce be sustainableMarket Sentiment Report & Consistent Income Trade Recommendations - newser.com
Top chart patterns to watch in RAPT Therapeutics Inc.Layoff News & Free Weekly Chart Analysis and Trade Guides - newser.com
Market reaction to RAPT Therapeutics Inc.’s recent newsRate Hike & Reliable Price Breakout Signals - newser.com
Why RAPT Therapeutics Inc. stock is seen as undervalued2025 Biggest Moves & Free Safe Capital Growth Stock Tips - newser.com
Rapt Therapeutics (NASDAQ:RAPT) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Does RAPT Therapeutics Inc. qualify in momentum factor screening2025 Macro Impact & Breakout Confirmation Trade Signals - newser.com
What drives RAPT Therapeutics Inc 0RA0 stock priceTrade Execution Strategies & Identify Winning Stocks - earlytimes.in
Rapt Therapeutics (NASDAQ:RAPT) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
How to use a screener to detect RAPT Therapeutics Inc. breakoutsPortfolio Profit Report & Long Hold Capital Preservation Tips - newser.com
Can swing trading help recover from RAPT Therapeutics Inc. lossesWeekly Gains Report & High Accuracy Trade Signal Alerts - newser.com
Rapt Therapeutics (NASDAQ:RAPT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Why RAPT Therapeutics Inc. (0RA0) stock stays on top picksWeekly Gains Report & Free Daily Entry Point Trade Alerts - newser.com
Is RAPT Therapeutics Inc. (0RA) stock bottoming after sell offQuarterly Profit Summary & High Conviction Buy Zone Picks - newser.com
Rapt Therapeutics (NASDAQ:RAPT) Sets New 12-Month HighTime to Buy? - MarketBeat
How RAPT Therapeutics Inc. (0RA) stock performs in volatility spikesJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Published on: 2025-10-02 21:38:33 - newser.com
Rapt Therapeutics Inc Azioni (RAPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):